Alethea Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,830
| Closed | -$393K | – | 27 |
|
|
2024
Q4 | $393K | Buy |
+14,830
| New | +$402K | 0.34% | 13 |
|
|
2024
Q2 | – | Sell |
-15,874
| Closed | -$441K | – | 43 |
|
|
2024
Q1 | $441K | Buy |
+15,874
| New | +$440K | 0.36% | 27 |
|
|
2023
Q3 | – | Sell |
-20,349
| Closed | -$746K | – | 65 |
|
|
2023
Q2 | $746K | Buy |
20,349
+14,849
| +270% | +$578K | 0.8% | 11 |
|
|
2023
Q1 | $224K | Sell |
5,500
-1,689
| -23% | -$72.9K | 0.24% | 55 |
|
|
2022
Q4 | $368K | Buy |
7,189
+1,689
| +31% | +$81K | 0.35% | 15 |
|
|
2022
Q3 | $241K | Hold |
5,500
| – | – | 0.3% | 51 |
|
|
2022
Q2 | $288K | Hold |
5,500
| – | – | 0.36% | 53 |
|
|
2022
Q1 | $285K | Hold |
5,500
| – | – | 0.26% | 56 |
|
|
2021
Q4 | $325K | Hold |
5,500
| – | – | 0.28% | 55 |
|
|
2021
Q3 | $237K | Hold |
5,500
| – | – | 0.21% | 69 |
|
|
2021
Q2 | $215K | Sell |
5,500
-2,282
| -29% | -$88.7K | 0.14% | 75 |
|
|
2021
Q1 | $282K | Buy |
7,782
+2,282
| +41% | +$81K | 0.17% | 64 |
|
|
2020
Q4 | $202K | Sell |
5,500
-19,498
| -78% | -$715K | 0.1% | 68 |
|
|
2020
Q3 | $870K | Buy |
+24,998
| New | +$876K | 0.59% | 21 |
|
|
2019
Q1 | – | Sell |
-37,289
| Closed | -$1.54M | – | 90 |
|
|
2018
Q4 | $1.54M | Buy |
+37,289
| New | +$1.55M | 2.25% | 9 |
|
|
2018
Q2 | – | Sell |
-12,598
| Closed | -$424K | – | 93 |
|
|
2018
Q1 | $424K | Hold |
12,598
| – | – | 0.58% | 57 |
|
|
2017
Q4 | $433K | Hold |
12,598
| – | – | 0.69% | 48 |
|
|
2017
Q3 | $427K | Sell |
12,598
-3,356
| -21% | -$108K | 0.5% | 53 |
|
|
2017
Q2 | $508K | Hold |
15,954
| – | – | 0.58% | 51 |
|
|
2017
Q1 | $518K | Hold |
15,954
| – | – | 0.62% | 43 |
|
|
2016
Q4 | $492K | Sell |
15,954
-60,971
| -79% | -$1.86M | 0.62% | 46 |
|
|
2016
Q3 | $2.47M | Buy |
76,925
+60,971
| +382% | +$2.04M | 3.43% | 2 |
|
|
2016
Q2 | $533K | Hold |
15,954
| – | – | 0.73% | 43 |
|
|
2016
Q1 | $449K | Sell |
15,954
-169
| -1% | -$4.83K | 0.5% | 46 |
|
|
2015
Q4 | $494K | Sell |
16,123
-10,548
| -40% | -$332K | 0.57% | 47 |
|
|
2015
Q3 | $795K | Buy |
26,671
+11,069
| +71% | +$355K | 1.21% | 27 |
|
|
2015
Q2 | $496K | Buy |
+15,602
| New | +$508K | 0.76% | 26 |
|
Other funds holding PFE
TIM
Alethea Capital Management's PFE Position: Q1 2025 in Review
Alethea Capital Management sold out of Pfizer (PFE) in Q1 2025, closing a stake of 14,830 shares — an estimated $393K sold.
Alethea Capital Management first reported a position in PFE in Q2 2015 and held it in 27 quarters. The position peaked at $2.47M in Q3 2016. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Alethea Capital Management reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
- Alethea Capital Management sold 14,830 Pfizer shares in Q1 2025, an estimated $393K.
- Alethea Capital Management first reported a position in Pfizer in Q2 2015 and held it in 27 quarters.
- Alethea Capital Management's Pfizer position peaked at $2.47M in Q3 2016.
- 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Alethea Capital Management's 13F filing for Q1 2025, filed 14 May 2025.